Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Inhibition of the Renin Angiotensin System With Losartan in Patients With Hypertrophic Cardiomyopathy (INHERIT)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Henning Bundgaard, Rigshospitalet, Denmark
ClinicalTrials.gov Identifier:
NCT01447654
First received: October 4, 2011
Last updated: July 8, 2014
Last verified: July 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2014
  Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):